Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| D. E. Shaw & Co., L.P. | XPOF Xponential Fitness, Inc. | 13G/A | 7.5% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | CLW Clearwater Paper Corp | 13G/A | 8.1% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | NKTR Nektar Therapeutics | 13G/A | 9.65% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | USAP Universal Stainless & Alloy | 13G/A | 4.11% | Dec 31, 2023 | 2y |
| Strategic Value Investors LP | SBFG Sb Financial Group, Inc. | 13G/A | 5.2% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | AIOT Powerfleet, Inc. | 13G | 9.2% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | TRCA Twin Ridge Capital Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| BIGLARI CAPITAL CORP. | LOCO El Pollo Loco Holdings, Inc. | 13G/A | 12.5% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | AUTL Autolus Therapeutics plc | 13G/A | 6.82% | Dec 31, 2023 | 2y |
| Lytton, Laurence W. | RVSN Rail Vision Ltd. | 13G/A | 9.3% | Dec 31, 2023 | 2y |
| Huazhi Hu | EH EHang Holdings Ltd | 13G/A | 31.5% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | GDRX GoodRx Holdings, Inc. | 13G | 7.58% | Dec 31, 2023 | 2y |
| NOMURA HOLDINGS INC | HGAS Global Gas Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | FBRX Forte Biosciences, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| Shaolin Capital Management LLC | CLRCF ClimateRock | 13G/A | 5.76% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | BVS Bioventus Inc. | 13G/A | 9.5% | Dec 31, 2023 | 2y |
| Ionic Ventures, LLC | ZVSA ZyVersa Therapeutics, Inc. | 13G/A | 4% | Dec 31, 2023 | 2y |
| Churchill Sponsor IV LLC | LCID Lucid Group, Inc. | 13G/A | 1.39% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | GTBP GT Biopharma, Inc. | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| Royal Bank of Canada | ARMK Aramark | 13G/A | 2.2% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | XAGE Longevity Health Holdings, Inc. | 13G | 7.55% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | WY Weyerhaeuser Co | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| EVENTIDE ASSET MANAGEMENT, LLC | PRAX Praxis Precision Medicines, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| GREENLIGHT CAPITAL INC | TLIS Talis Biomedical Corporation Common Stock | 13G/A | 8.2% | Dec 31, 2023 | 2y |
| CVI Investments, Inc. | GNPX Genprex, Inc. | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | MCAA Mountain & Co. I Acquisition Corp. Class A Ordinary Shares | 13G | 8.7% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | ESYN EnerSyn Global Inc. | 13G | 7.71% | Dec 31, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | ALGS Aligos Therapeutics, Inc. | 13G/A | 3% | Dec 31, 2023 | 2y |
| Granahan Investment Management, LLC | LOVE Lovesac Co | 13G/A | 9.21% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | TEAM Atlassian Corp | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| ORBIMED ADVISORS LLC | SIBN SI-BONE, Inc. | 13G/A | 5.3% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | KALV KalVista Pharmaceuticals, Inc. | 13G/A | 14% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | CELC Celcuity Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | EOSE Eos Energy Enterprises, Inc. | 13G/A | 2% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | SUI Sun Communities Inc | 13G/A | 11.14% | Dec 31, 2023 | 2y |
| Whitefort Capital Management, LP | CEE Central & Eastern Europe Fund, Inc. | 13G/A | 4.8% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | VVOS Vivos Therapeutics, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | RMGC RMG Acquisition Corp. III Class A Ordinary Shares | 13G | 5.47% | Dec 31, 2023 | 2y |
| Insight Acquisition Sponsor LLC | AMOD Alpha Modus Holdings, Inc. | 13G/A | 76% | Dec 31, 2023 | 2y |
| NB Alternatives Advisers LLC | OPRT Oportun Financial Corp | 13G | 9.9% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | ABEO Abeona Therapeutics Inc. | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | MGYR Magyar Bancorp, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Walleye Capital LLC | RMGC RMG Acquisition Corp. III Class A Ordinary Shares | 13G | 40.51% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | BNAI Brand Engagement Network Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Westchester Capital Management, LLC | CVII Churchill Capital Corp VII Class A Common Stock | 13G | 7.07% | Dec 31, 2023 | 2y |
| Hood River Capital Management LLC | HCI HCI Group, Inc. | 13G | 7.43% | Dec 31, 2023 | 2y |
| Lion Point Capital, LP | DRRX Durect Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| Sandia Investment Management LP | SEDA SDCL EDGE Acquisition Corporation | 13G/A | 10.62% | Dec 31, 2023 | 2y |
| Schonfeld Strategic Advisors LLC | GCMG GCM Grosvenor Inc. | 13G/A | 0.1% | Dec 31, 2023 | 2y |
| TTWFGP LLC | WLK Westlake Corp | 13G/A | 72.9% | Dec 31, 2023 | 2y |